Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.
New Life Expands Prestige Recovery Services To The Middle East
MARBELLA, Spain, Sept. 17, 2025 (GLOBE NEWSWIRE) -- New Life announces expansion of its luxury wellness and recovery services to Dubai and Abu Dhabi through a strategic partnership with Aims Healthcare. New Life Expands Into the Middle East New...
Joint statement: offer to assist with treatments of patients from Gaza in the Occupied West Bank, including East Jerusalem
SLOVENIA, September 23 - We, the undersigned, stand ready to provide support in the form of e.g. financial contributions, provision of medical staff or equipment needed for the treatment of patients from Gaza in the occupied West Bank, including...
Owner: Slovenian Government
Oculis to Participate in Upcoming September Investor Conferences
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...
Higher Levels of Trust Determine 2025 Fortune 100 Best Companies to Work For Europe
Oakland, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Great Place To Work® announced the 2025 Fortune 100 Best Companies to Work For™ Europe, marking its second year of partnering with Fortune Europe. To select the list, Great Place To Work surveyed...
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
Costco Wholesale Corporation Reports September Sales Results
ISSAQUAH, Wash., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $26.58 billion for the retail month of September, the five weeks ended October 5, 2025, an...
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet...
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda...
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the...
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...
ASP Isotopes Inc. Announces Changes to the Executive Management Teams of ASP Isotopes Inc. and Quantum Leap Energy LLC Effective October 2025
- ASP Isotopes Inc. appoints Interim CEO as Paul Mann becomes Executive Chairman. - Quantum Leap Energy LLC appoints Michael Cunniffe as CFO. - ASP Isotopes Inc. provides information on upcoming investor events. WASHINGTON, Sept. 29, 2025 (GLOBE...
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq...
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial demonstrating Rezdiffra reduced...
Oculis Reports Q2 2025 Financial Results and Provides Company Update
Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first potential eye drop to treat...
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders...
SEALSQ and Kaynes SemiCon Announce Joint Venture to Establish India's First Secure Semiconductor Center for Onshore Personalization and Quantum-Resistant Technology
Geneva, Switzerland / India, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products,,...
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Approval is based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity EC approval follows positive CHMP opinion, MHRA conditional marketing...
Lobster Market Size USD 7.88 Bn in 2024 Trends, Share, Growth, Key Players & Forecast to USD 15.93 Bn | Seafood Insights
The Lobster Market was valued at USD 7.88 Bn. in 2024 and is expected to grow at a CAGR of 9.2% from 2025 to 2032, reaching nearly USD 15.93 Bn. by 2032. WILMINGTON, DE, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- Explore the Lobster...